PARIS, Oct 4 (Reuters) - Sanofi Pasteur MSD said it aimed to extend the use of its cervical cancer vaccine treatment Gardasil, which is battling to win market share against the rival drug Cervarix developed by GlaxoSmithKline (GSK.L: Quote, Profile, Research).
